» Articles » PMID: 31445025

Downregulation of Hsa_circ_0007534 Restricts the Proliferation and Invasion of Cervical Cancer Through Regulating MiR-498/BMI-1 Signaling

Overview
Journal Life Sci
Publisher Elsevier
Date 2019 Aug 25
PMID 31445025
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Hsa_circ_0007534 has been reported to be a novel cancer-related circRNA affecting multiple cancers. However, little is known about the role of hsa_circ_0007534 in cervical cancer specifically. In the current study, we aimed to explore the expression and function of hsa_circ_0007534 in cervical cancer.

Main Methods: The expression of circRNA, miRNA and mRNA was measured using real-time quantitative polymerase chain reactions. Protein expression was assessed by Western blot. Knockdown of has_circ_0007534 was achieved by siRNA-mediated gene silencing. Cell proliferation was determined using a cell counting kit-8 and colony formation assays. Cell invasion was assessed using a Transwell invasion assay. RNA interactions were measured using an RNA pull-down and dual-luciferase reporter assays.

Key Findings: The expression of hsa_circ_0007534 was upregulated in cervical cancer tissues and cell lines. Depletion of hsa_circ_0007534 decreased both the proliferation and invasion of cervical cancer cells. MicroRNA-498 (miR-498) was identified as a target of the miRNA encoded by hsa_circ_0007534. Levels of miR-498 were decreased in cervical cancer tissues, a finding that was inversely correlated with hsa_circ_0007534 expression. miR-498 overexpression repressed the proliferation and invasion of cervical cancer cells. B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) was verified as a target gene of miR-498. BMI-1 overexpression reversed the effects of hsa_circ_0007534 depletion or miR-498 overexpression on cervical cancer cell proliferation and invasion.

Significance: Our study demonstrates that downregulation of hsa_circ_0007534 represses the proliferation and invasion of cervical cancer through regulating the miR-498/BMI-1 axis, suggesting the hsa_circ_0007534/miR-498/BMI-1 axis as a potential therapeutic target to treat cervical cancer.

Citing Articles

Progress and prospects of the combination of BMI1-targeted therapy and immunotherapy in cervical cancer.

Chen Y, Liu S, Yin X Am J Cancer Res. 2025; 15(1):217-232.

PMID: 39949922 PMC: 11815372. DOI: 10.62347/QTWJ8918.


Hsa_circ_0009910 knockdown in HeLa cells increases miR‑198 expression levels and decreases c‑Met expression levels and cell viability.

Tolentino-Molina B, Loaeza-Loaeza J, Ortega-Soto A, Castro-Coronel Y, Fernandez-Tilapa G, Hernandez-Sotelo D Oncol Lett. 2024; 29(2):74.

PMID: 39650233 PMC: 11622005. DOI: 10.3892/ol.2024.14820.


Serum hsa_circ_0007534 as a diagnostic biomarker for ovarian cancer.

Cao M, Gu Y, Lv B, Liu S, Shen Y Am J Transl Res. 2024; 16(10):5630-5636.

PMID: 39544800 PMC: 11558420. DOI: 10.62347/KHAK2629.


circRNF13, a novel N-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability.

Shi J, Rui X, Han C, Wang C, Xu L, Jiang X Cell Death Discov. 2023; 9(1):253.

PMID: 37468464 PMC: 10356927. DOI: 10.1038/s41420-023-01557-0.


circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.

Liu S, Yuan L, Li J, Liu Y, Wang H, Ren X Ann Med. 2023; 55(1):908-919.

PMID: 36896567 PMC: 10795628. DOI: 10.1080/07853890.2023.2185289.